drugset / Trial / NCT00296361

To Compare the Efficacy and Safety of a Therapy of Tacrolimus With Sirolimus or MMF in Kidney Transplantation.

NCT00296361

Phase 3 Completed 634 enrolled Astellas Pharma Inc
RandomizedParallel-groupOpen-labelPrevention

Summary

Primary objective of this study is to compare the two therapy regimens with regard to renal function by using calculated creatinine clearance. The secondary objectives are to compare the efficacy and safety profiles of the two therapy regimens.

Timeline

Start
2004-10
Primary completion
2006-07
Completion
2006-07

Drugs

EvaluationDrugModalityDoseRoute
Background Tacrolimus Small molecule

Indications

No indication recorded.